Defiance Launches RKLX and HIMZ: 2X Leveraged ETFs for Rocket Lab and Hims & Hers

Company Overview - Defiance ETFs has launched two 2X leveraged single-stock ETFs, RKLX and HIMZ, aimed at providing amplified exposure to Rocket Lab USA, Inc. (NASDAQ: RKLB) and Hims & Hers Health Inc. (NYSE: HIMS) [1][2] - These ETFs allow traders to seek enhanced returns on Rocket Lab and Hims & Hers without the need for a margin account [1][2] Industry Insights - Rocket Lab is positioned in the satellite technology sector, focusing on satellite launches, space exploration, and advanced aerospace systems [8] - Hims & Hers operates in the digital healthcare sector, pioneering telehealth and direct-to-consumer healthcare solutions [8] - Both companies are noted for driving innovation in their respective industries, with increasing demand for their services [2] Investment Strategy - RKLX seeks daily investment results that correspond to twice (200%) the daily percentage change of Rocket Lab [8] - HIMZ aims for daily investment results that correspond to twice (200%) the daily return of Hims & Hers [8] - The funds are designed for knowledgeable investors who understand the risks associated with leveraged investments and are willing to actively manage their portfolios [2][4]